CHAPEL HILL, N.C.--(BUSINESS WIRE)--POZEN Inc. (NASDAQ: POZN), a pharmaceutical company committed to transforming medicine that transforms lives, announced today that Elizabeth Cermak, the Company’s Executive Vice President and Chief Commercial Officer, will participate in the UBS Specialty Pharmaceuticals Mini 1x1 Conference on Monday, June 27, 2011 in Boston.
